Reuters Staff
1 Min Read
April 2 (Reuters) - Soleno Therapeutics Inc:
* Q4 LOSS PER SHARE $0.39 FROM CONTINUING OPERATIONS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)